Vanderbilt Diabetes Research and Training Center (DRTC)

From left are Alvin Powers, MD, Daniel Drucker, MD, and Steven Eskind, MD, associate professor of Surgery, son of Annette and Irwin Eskind. (photo by Donn Jones)

Leading GLP-1 expert shares insights on groundbreaking drugs for glucose control, weight loss

Drucker and his team study the molecular biology and physiology of the GLP-1 and GLP-2 molecules that regulate glucose metabolism, insulin secretion and energy balance.

Danielle Dean, PhD

Danielle Dean receives award for excellence in the field of islet research

Dean identified a liver-alpha cell axis (LACA), a crosstalk between liver glucagon signaling and alpha cell sensing of amino acids.

Terri Doss, second from right, a research assistant at the Vanderbilt Mouse Metabolic Phenotyping Center, received the Robert K. Hall Service Award for her outstanding contributions to the diabetes research community. Young investigators receiving awards at Diabetes Day are, left to right, Kathryn Snyder, MD, MPH; Darian Carroll; Doss and Dudley McNitt, PhD. Not pictured is Emily Hawes, PhD. (photo by Susan Urmy)

Diabetes Day spotlights achievements, current investigations

Today, the Vanderbilt Diabetes Research and Training Center includes 140 faculty members from 15 departments and three colleges or schools at Vanderbilt and Meharry Medical College who conduct basic, clinical and translational research on the cause, prevention, treatment and complications of diabetes and obesity.

Study links small pancreas size to faster progression to stage 3 Type 1 diabetes

The study findings, published in the journal Diabetes Care, suggest that pancreas imaging can have a benefit in tracking disease development and recruitment for preventive and therapeutic trials.

Study links gene network and pancreatic beta cell defects to Type 2 diabetes

A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes.

Powers announces plan to step down from key diabetes leadership roles

Alvin C. Powers, MD, has announced plans to step down effective July 1, 2024, as director of the Vanderbilt Diabetes Center, director of the Vanderbilt Diabetes Research and Training Center, and chief of the Division of Diabetes, Endocrinology and Metabolism.

1 2 3